Do Inhaled Anticholinergics Increase or Decrease the Risk of Major Cardiovascular Events?: A Synthesis of the Available Evidence

By Salpeter Shelley R.  

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2025-2033

Adis International

Access to resources Recommend Favorite

COX-2 inhibitors: increased risk of CV events?

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

NSAIDs and the risk of CV events: is there a class effect?

By  

Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Do Some Inhibitors of COX-2 Increase the Risk of Thromboembolic Events?: Linking Pharmacology with Pharmacoepidemiology

By Clark D.W.J.   Layton D.   Shakir S.A.W.  

Drug Safety, Vol. 27, Iss. 7, 2004-01 ,pp. : 427-456

Adis International

Access to resources Recommend Favorite

NSAID-Related Psychiatric Adverse Events: Who is at Risk?

By Graziano Onder   Francesca Pellicciotti   Giovanni Gambassi   Roberto Bernabei  

Drugs, Vol. 64, Iss. 23, 2004-01 ,pp. : 2619-2627

Adis International

Access to resources Recommend Favorite